Uptake Kinetics, Species Differences, and the Determination of Equivalent Combinations of Air Concentration and Exposure Duration for Assessment of Acute Inhalation Toxicity

REFERENCES

• Abraham , K , Mielke , H Huisinga , W . 2005 . Elevated internal exposure of children in simulated acute inhalation of volatile organic compounds: Effects of concentration and duration . Arch Toxicol , 79 ( 2 ) : 63 – 73 .
   PubMed Web of Science ®Google Scholar
• Adolph , E F . 1949 . Quantitative relations in the physiological constitution of mammals . Science , 109 : 579 – 85 .
   PubMed Web of Science ®Google Scholar
• Bos , P M , Zeilmaker , M J and van Eijkeren , J C . 2006 . Application of physiologically based pharmacokinetic modeling in setting acute exposure guideline levels for methylene chloride . Toxicol Sci , 91 ( 2 ) : 576 – 85 .
   PubMed Web of Science ®Google Scholar
• Boxenbaum , H . 1982 . Interspecies scaling, allometry, physiological time, and the ground plan of pharmacokinetics . J Pharmacol Biopharm , 10 : 201 – 27 .
   PubMedGoogle Scholar
• Boxenbaum , H . 1983 . Evolutionary biology, animal behavior, fourth-dimensional space, and the raison d'être of drug metabolism and pharmacokinetics . Pharmacol Biopharm , 10 : 201 – 27 .
   Google Scholar
• Boxenbaum , H . 1984 . Interspecies pharmacokinetic scaling and the evolutionary-comparative paradigm . Drug Metab Rev , 15 : 1071 – 121 .
   PubMed Web of Science ®Google Scholar
• Boxenbaum , H . 1986 . Time concepts in physics, biology, and pharmacokinetics . J Pharmacol Sci , 75 : 1053 – 62 .
   PubMed Web of Science ®Google Scholar
• Boyes , W K , Evans , M V Eklund , C . 2005 . Duration adjustment of acute exposure guideline level values for trichloroethylene using a physiologically-based pharmacokinetic model . Risk Anal , 25 ( 3 ) : 677 – 86 .
   PubMed Web of Science ®Google Scholar
• Brown , R P , Delp , M D Lindstedt , S L . 1997 . Physiological parameter values for physiologically based pharmacokinetic models . Toxicology and Industrial Health , 13 ( 4 ) : 407 – 84 .
   PubMed Web of Science ®Google Scholar
• Bruckner , J V , Keys , D A and Fisher , J W . 2004 . The Acute Exposure Guideline Level (AEGL) program: Applications of physiologically based pharmacokinetic modeling . J Toxicol Environ Health A , 67 ( 8–10 ) : 621 – 34 .
   PubMed Web of Science ®Google Scholar
• Dedrick , R L . 1973 . Animal scale-up . Pharma Biopharm , 1 : 435 – 61 .
   PubMedGoogle Scholar
• Dedrick , R O , Bischoff , K B and Zaharko , D S . 1970 . Interspecies correlation of plasma concentration history of methotrexate (NSC-740) . Cancer Chemother Rep. Pt 1. , 54 : 95 – 101 .
   PubMedGoogle Scholar
• Gibaldi , M . 1984 . Biopharmaceutics and Clinical Pharmacokinetics , Philadelphia, PA, , USA : Lea & Febiger .
   Google Scholar
• Haber , F , ed. 1924 . “ Zur Geschichte des Gaskrieges ” . In Fünf Vorträge aus den Jahren 1920–1923 , 37 – 106 . Berlin, , Germany : Springer .
   Google Scholar
• Ings , R JM . 1990 . Interspecies scaling and comparisons in drug development and toxicokinetics . Xenobiotica , 20 : 1201 – 31 .
   PubMed Web of Science ®Google Scholar
• Kleiber , M . 1932 . Body size and metabolism . Hilgardia. , 6 : 315 – 53 .
   Google Scholar
• Lindstedt , S L . 1987 . “ Alloemtry: Body size contraints in animal design ” . In Pharmacokinetics in Risk Assessment: Drinking Water and Health, vol 8 , Edited by: Gillette , J R , Jollow , D J , Andersen , M E , Bischoff , K B , Davis , M E , Dedrick , R L , Friess , S L , Krewski , D , Menzeli , D B , Prough , R A , Reitz , R H , Travis , C C and Wilkinson , G R . 65 – 79 . Washington, DC, , USA : National Academy Press .
   Google Scholar
• Lindstedt , S L and Calder , W A . 1976 . Body size and longevity in birds . Condor. , 78 : 91 – 4 .
   Web of Science ®Google Scholar
• Lindsted , S L and Calder , W A . 1981 . Body size, physiological time, and longevity of homeothermic animals. Quart. Rev . Biol. , 56 : 1 – 16 .
   Google Scholar
• McMahon , T A and Bonner , J T . 1983 . On Size and Life , New York, NY, , USA : Scientific American Books .
   Google Scholar
• Mielke , H , Gundert , A Abraham , K . 2005 . Acute inhalative exposure assessment: Derivation of guideline levels with special regard to sensitive subpopulations and time scaling . Toxicology , 214 ( 3 ) : 256 – 67 .
   PubMed Web of Science ®Google Scholar
• Miller , F J , Schlosser , P M and Janszen , D B . 2000 . Haber's rule: A special case in a family of curves relating concentration and duration of exposure to a fixed level of response for a given endpoint . Toxicology , 149 : 21 – 34 .
   PubMed Web of Science ®Google Scholar
• Mordenti , J . 1986 . Man versus beast: Pharmacokinetic scaling in mammals . J Pharmacol Sci , 75 : 1028 – 40 .
   PubMed Web of Science ®Google Scholar
• Ng , L G , Stuhmiller , L M and Stuhmiller , J H . 2007 . Incorporation of acute dynamic ventilation changes into a standardized physiologically based pharmacokinetic model . Inhal Toxicol , 19 ( 3 ) : 247 – 63 .
   PubMed Web of Science ®Google Scholar
• NRC (National Research Council) . 2001 . Standing Operating Procedures for Developing Acute Exposure Guidelines for Hazardous Chemicals , Washington, DC, , USA : National Academy Press .
   Google Scholar
• O'Flaherty , E L . 1989 . Interspecies conversion of kinetically equivalent doses . Risk Anal , 9 : 587 – 98 .
   Web of Science ®Google Scholar
• Ostwald , W and Dernoschek , A . 1910 . Über die Bezichungen zwischen Adsorption und Giftigkeit . Kolloid-Zeitschr , 6 : 297 – 307 .
   Google Scholar
• Peters , R H . 1983 . The Ecological Implications of Body Size , New York, NY, , USA : Cambridge University Press .
   Google Scholar
• Rhomberg , L R . 2002 . Dose scaling and extrapolation across age groups . Hum Ecol Risk Assess , 8 : 783 – 803 .
   Web of Science ®Google Scholar
• Rhomberg , L R and Lewandowski , T A . 2006 . Methods for identifying a default cross-species scaling factor . Hum Ecol Risk Assess , 12 : 1094 – 127 .
   Web of Science ®Google Scholar
• Saltzman , B E . 1996 . Assessment of health effects of fluctuating concentrations using simplified pharmacokinetic algorithms . J Air & Waste Manage Assoc , 46 : 1022 – 34 .
   PubMedGoogle Scholar
• Schmidt-Neilsen , K . 1970 . Energy metabolism, body size, and problems of scaling . Fed Proc , 29 : 1524 – 32 .
   PubMedGoogle Scholar
• Schmidt-Neilsen , K . 1975 . Scaling in biology: The consequences of size . J Exp Zool , 194 : 287 – 308 .
   PubMedGoogle Scholar
• Schmidt-Neilsen , K . 1984 . Scaling: Why is Animal Size so Important? , New York, NY, , USA : Cambridge University Press .
   Google Scholar
• Strickland , J A and Foureman , G L . 2002 . U.S. EPA's acute reference exposure methodology for acute inhalation exposures . Sci Total Environ , 288 : 51 – 63 .
   PubMed Web of Science ®Google Scholar
• ten Berge , W F , Zwart , A and Appelman , L M . 1986 . Concentration-time mortality response relationship of irritant and systematically acting vapours and gases . J Haz Mat , 13 : 301 – 9 .
   Web of Science ®Google Scholar
• Travis , C C , White , R K and Ward , R C . 1990 . Interspecies extrapolation of pharmacokinetics . J Theor Biol , 142 : 285 – 304 .
   PubMed Web of Science ®Google Scholar
• USEPA (US Environmental Protection Agency) . 1992 . Draft report: A cross-species scaling factor for carcinogen risk assessment based on equivalence of mg/kg3/4/day . Fed Reg , 57 ( 109 ) : 24152 – 73 .
   Google Scholar
• USEPA . 2005 . Guidelines for Carcinogen Risk Assessment (Final) , Washington, DC, , USA : Risk Assessment Forum . EPA/630/P-03/001B
   Google Scholar
• Witschi , H . 1999 . Some notes on the history of Haber's law . Toxicol Sci , 50 : 164 – 8 .
   PubMed Web of Science ®Google Scholar
• Woodall , G M . 2005 . Acute health reference values: Overview, perspectives and current forecast of needs . J Toxicol Environ Health A , 68 : 901 – 26 .
   PubMed Web of Science ®Google Scholar